MRI Found to Be Useful in Predicting Multiple Sclerosis

Modified Barkhof criteria may have moderate value in predicting change to multiple sclerosis
By Eric Metcalf
HealthDay Reporter

WEDNESDAY, Nov. 11 (HealthDay News) -- In patients with a clinically isolated syndrome treated with interferon beta-1b, the modified Barkhof criteria may provide some value in predicting conversion to clinically definite multiple sclerosis (CDMS), according to a multicenter, randomized study published in the November issue of the Archives of Neurology.

Bastiaan Moraal, M.D., of the Vrije University Medical Center in Amsterdam, Netherlands, and colleagues analyzed data from 468 patients with a recent initial clinical demyelinating event. Patients either received three years of interferon beta-1b or placebo followed by at least a year of this treatment. All underwent baseline MRI.

Overall, the researchers found that 42 percent converted to CDMS. Of the Barkhof criteria, those with the highest prognostic value were the baseline presence of at least nine T2-weighted lesions and at least three periventricular lesions (hazard ratios, 1.64 and 1.66, respectively). The authors found no particular advantage in using at least three Barkhof criteria as a set cutoff.

"In general, the percentage of patients converting to CDMS was higher in the presence (compared with the absence) of all baseline MRI variables. In particular, the modified Barkhof criteria showed moderate predictive value for conversion to CDMS, although all patients were treated for at least one year with interferon beta-1b," the authors conclude.

The study was sponsored by Bayer Schering Pharma AG. Several authors reported financial and consulting relationships with a variety of pharmaceutical companies.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95


Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95


Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95


More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events